Zenas BioPharma Inc.
ZBIO | NASDAQ
$25.93
-$2.53 (-8.89%)
At close: Nov 5, 2026, 4:00 PM ET
$25.00
-$0.93 (-3.59%)
After-hours:
Nov 5, 2026, 5:09 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
PE Ratio | -4.30 | -2.18 | -18.53 | -5.78 |
PEG Ratio | -0.03 | -0.01 | 0.27 | n/a |
PS Ratio | 162.41 | 68.44 | 13.77 | n/a |
PB Ratio | 6.71 | 1.10 | -3.05 | -3.58 |
P/FCF Ratio | -9.42 | -2.86 | -22.54 | -10.15 |
P/OCF Ratio | -9.42 | -2.86 | -22.55 | -10.49 |
OCF/S Ratio | -1.72K | -2.39K | -61.06 | n/a |
Debt / Equity Ratio | 0.33 | 0 | -0.09 | -0.01 |
Quick Ratio | 5.61 | 6.21 | 2.57 | 2.64 |
Current Ratio | 5.61 | 6.21 | 2.57 | 2.64 |
Asset Turnover | 0.03 | 0.01 | 0.73 | n/a |
Interest Coverage | -28.85 | n/a | n/a | n/a |
Return on Equity | -156% | -50.24% | 16.45% | 62.03% |
Return on Assets | -98.46% | -42.43% | -54.45% | -159.94% |
Return on Invested Capital | -65.61% | -52.28% | -81.68% | -154.48% |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | -2.68K% | 100% | n/a |
Net Profit Margin | -3.78K% | -3.14K% | -74.25% | n/a |
Pretax Profit Margin | -3.78K% | -3.13K% | -73.65% | n/a |
Operating Profit Margin | -2.11K% | -3.28K% | -74.29% | n/a |
FCF Margin | -1.72K% | -2.4K% | -61.09% | n/a |
EBITDA Margin | -3.7K% | -3.13K% | -54.07% | n/a |
Add to Watchlist
Select watchlists to add or remove ZBIO